Intellectual Property

STOCKHOLM – November 03, 2026 -- The U.S. Patent and Trademark Office has granted Moberg Pharma a patent on an improved dosing regimen for MOB-015, its topical onychomycosis drug, with a projected expiry in December 2041. The U.S. is the first market to grant a patent on the new dosing.

Patent draws on European approval studies and North American Phase 3 data

The patent covers new dosing approaches for MOB-015. It rests on clinical results from the studies behind the European approval and from the company's most recently completed Phase 3 study in North America. Dosing patent applications in other markets remain under examination.

RALEIGH – November 02, 2026 -- RedHill Biopharma (NASDAQ: RDHL) said two independent in vitro studies confirmed that its Crohn's disease candidate RHB-204 kills Mycobacterium avium subspecies paratuberculosis (MAP) at a level comparable to RHB-104, which posted a 64% efficacy gain in a Phase 3 trial.

Two microbiology centers confirm MAP-killing in culture and phage assays

The studies used long-term intracellular culture and spot and phage assays. One was led by Professor Tim Bull of City St George's University of London. The other was led by Professor Irene Grant of Queen's University Belfast and Dr Hannah Dane, working with Rapid-myco Technologies.

TAMPA – October 29, 2026 -- Akari Therapeutics (Nasdaq: AKTX) has filed international patent application PCT/US2026/45955, adding claims on how its PH1 payload modulates alternative splicing across multiple cancer-driving genes.

The filing expands the company's intellectual property around PH1, a splicing-modulating payload derived from its proprietary Thailanstatin platform, and around PH1-based antibody drug conjugates (ADCs). Akari contrasts PH1 with conventional ADC payloads that rely on tubulin inhibition, such as vedotin, or DNA damage, such as topoisomerase I inhibitors.

Application claims PH1 shifts VEGF-A splicing to block tumor blood supply

The claims cover PH1 altering VEGF-A splicing in cancer cells. The shift moves from a pro-angiogenic isoform to the anti-angiogenic VEGF-165b isoform, which prevents blood vessel recruitment to tumors.

RENO – October 27, 2026 -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) has received a notice of allowance from the European Patent Office for its application "Systems and Methods for Dry Powder Coating Layers of an Electrochemical Cell," extending protection for its dry electrode manufacturing platform into Europe.

European Patent Office allows claims covering dry powder coating of cell layers

The allowed application covers key elements of the company's proprietary dry electrode manufacturing platform. The technology uses dry powder coating to form critical layers within an electrochemical cell. The process can support electrode, separator and solid-state electrolyte layers.

Dragonfly Energy, maker of Battle Born Batteries, says the allowance reinforces its intellectual property position in scalable, solvent-free battery manufacturing and all-solid-state battery development.

United States – October 17, 2026 -- AdvaMed has told the U.S. Copyright Office that software built to diagnose, configure and service a medical device is a distinct product and should not be treated like the software that operates the device.

AdvaMed separates clinician-facing software from servicing tools

The trade group's comments contrast two categories. One is software clinicians use to operate an imaging system. The other is software designed specifically to diagnose, configure and service that system. AdvaMed compares the split to a vehicle's operating software versus the specialized diagnostic tools technicians use to repair it. In its framing, one enables use of the product, while the other is a standalone tool with its own functions, users, protections and market.

Alexandria, Va. – October 16, 2026 -- A wallet-sized CPR guidance patch from the University of Washington and a radiation-scatter device from the University of Pittsburgh School of Medicine took the $10,000 first prizes at the 2026 Collegiate Inventors Competition, which drew 25 students from nine U.S. colleges and universities.

Ten finalist teams, five undergraduate and five graduate, presented to a final-round panel of National Inventors Hall of Fame Inductees and U.S. Patent and Trademark Office (USPTO) officials. Winning teams receive cash awards plus a USPTO Patent Acceleration Certificate. The competition, established in 1990, is a program of the National Inventors Hall of Fame and is sponsored by the USPTO.

Portland – October 15, 2026 -- Michael Lubitz, founder and Senior Managing Director of Global Technology Transfer Group (GTT Group), will moderate a 50-minute masterclass on structuring high-return patent deals at IAM Live: Patent Transactions 2026 on October 22 at the Hilton San Diego Bayfront.

Session targets buy-sell deal structuring with five corporate and funding panelists

The session, titled "Masterclass: Buy-Sell Patent Transactions That Pay," runs from 11:30 AM to 12:20 PM PDT. Lubitz, who also founded Ideaship, will lead a panel that draws on executives and funders from across the IP market.

The co-panelists are:

Kuala Lumpur – October 12, 2026 -- ASEAN Records Sdn. Bhd. has secured Indonesian trademark registration No. IDM001511852 for its logo and "Celebrates Regional Excellence" tagline, with protection running to 27 March 2036 under Class 41.

Indonesian IP authority recorded registration under Law No. 20 of 2016

Indonesia's Directorate General of Intellectual Property, part of the Ministry of Law, recorded the registration on 21 September 2026 under Application No. JID2026027569. The filing date was 27 March 2026. The protection period runs from 27 March 2026 to 27 March 2036 and is subject to renewal. The registration was made under Indonesia's Law No. 20 of 2016 concerning Marks and Geographical Indications.

Class 41 filing covers award ceremonies, conferences and cultural events

The registration covers the following services:

Shenzhen, China – – October 08, 2026 -- The High People's Court of Guangdong Province has issued a final, legally binding judgment in favor of Shenzhen Leqi Innovation Co., Ltd., the company behind imaging accessories brand SmallRig, in a design patent infringement case against Shenzhen Neewer Technology Co., Ltd. and Shenzhen Xing Ying Da Industry Co., Ltd.

Court dismisses Neewer's appeal and upholds full damages award

The court ruled that the accused side handle products fall within the scope of protection of Leqi Innovation's design patent, dismissing Neewer Technology's appeal and affirming the trial court's judgment in its entirety. The two defendants were ordered to cease manufacturing and selling the infringing side handles, destroy remaining inventory and related promotional materials, bear all court costs, and pay damages to Leqi Innovation. The damages have been paid in full.

Pittsburgh – October 07, 2026 -- An InventHelp client has filed a patent application for the Hammersmith Rifle, Model SG 25, an ambidextrous service rifle platform designed to be reconfigured by individual operators for fit and field conditions, and is now seeking manufacturers or marketers for licensing.

Design targets user-specific fit and recoil management

The Model SG 25 features an adjustable side-folding stock and a pistol grip that can be set to the shooter's preferred length of pull and hand size. An adjustable gas and operating system lets operators tune the weapon to their recoil tolerance and to varying environmental conditions.